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1. INTRODUCTION
Carotenoids represent a large class of terpenoids characterized by an extensively conjugated
polyene chain. The conjugation system imparts carotenoids with excellent light absorbing
properties in the blue-green (450–550 nm) range of the visible spectrum. The light-
absorbing properties of carotenoids have been exploited by photosynthetic organisms to
extend the range of light absorption by the photosynthetic apparatus beyond that of
chlorophyll. 1 Following light absorption the carotenoid excited state undergoes excitation
energy transfer to chlorophyll. 2 In addition to their role as accessory pigments, carotenoids
protect against excess light by quenching both singlet and triplet state chlorophylls. In plants
oxygenated carotenoids, known as xanthophylls, provide additional photoprotective
functions by non-photochemical quenching (NPQ) of chlorophyll fluorescence. 2a,3
Carotenoids carry out light independent functions in scavenging peroxyl radicals and
preventing oxidative damage particularly against singlet oxygen (1O2).4 Since many
organisms and specific animal tissues, such as the macula lutea and the corpus luteum,
accumulate large amounts of carotenoids, it was proposed that carotenoids may protect
against the damaging effects of oxidative stress in such tissues. 5a,b These properties have
prompted much research in the chemopreventative potential of carotenoids. At high oxygen
pressures, however, some carotenoids display prooxidative activity4b and some β-carotene
formulations have even shown adverse effects in supplementation trials aimed at preventing
lung cancer in smokers. 6
The length of the carotenoid polyene chain corresponds to the width of the phospholipid
bilayer, which led to the proposal that carotenoids act as “molecular rivets” to stabilize and
add rigidity to the phospholipid membrane. 2b,7 The membrane spanning topology could
also allow carotenoids to counteract oxidative damage on either side of the membrane. 4b It
has also been proposed that membrane-spanning carotenoids can mediate proton transfer
across the membrane or serve as transmembrane radical channels. 8
Due to their striking and rich color carotenoids are important floral pigments serving to
attract pollinators and seed dispersers. 9 In birds and fish, carotenoids are an important
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signal of good nutritional condition and are used in ornamental displays as a sign of fitness
and to increase sexual attractiveness. 10a,b,c,10d–f
Following oxidative cleavage, carotenoids generate apocarotenoid metabolites which serve
important signaling and photoreceptive functions. The 11-cis isomers, 11-cis-retinaldehyde,
3,4-didehydro-11-cis-retinaldehyde or 3-hydroxy-11-cis-retinal are used by most animals as
a photosensitive moiety coupled to the opsin protein, rhodopsin, cone opsin or
melanopsin. 11 These photoreceptor molecules mediate vision and circadian
photoentrainment. 12 Bacteria use the light-sensitive carotenoid cleavage product,
retinaldehyde, coupled to bacteriorhodopsin and related proteins to transport protons and
other ions across the membrane. This ion transport function allows the cell to generate
energy, regulate ion balance or sense light. 13a,b,c
The acidic forms of several apocarotenoids act as signaling molecules in fungi, plants and
vertebrates. The apocarotenoid, trisporic acid, signals mating type in fungi. 14 Plants cleave
carotenoids such as 9-cis-neoxanthin to generate the hormone abscisic acid, which plays
important roles in inducing seed dormancy, and allowing the plant to adapt to abiotic
stress. 15a,b,c Other plant apocarotenoid metabolites, such as strigolactones trigger seed
germination of parasitic weeds and inhibit shoot branching. 16 Finally, vertebrates use
retinoic acid, a ligand for nuclear receptors to regulate gene transcription in physiological
processes that include embryonic development, cell differentiation, and immunity. 17a–c,17d,e
Carotenogenesis occurs in all photosynthetic organisms and in some non-photosynthetic
bacteria, archaea, protozoa and fungi. Reflecting their ubiquitous presence and pleiotropic
roles there are well over 700 different types of carotenoids generated through variations of
their pathways of synthesis. 18 There is even recent evidence for the acquisition of
carotenogenic enzymes by metazoans through lateral gene transfer from endosymbiotic
fungi. 19 Many excellent reviews have focused on the later steps of the carotenoid synthetic
pathways and their regulation in bacteria, and plants. 20,21 In this review we concentrate on
the mechanisms of carotenoid synthesis by examining the structure and enzymology of
enzymes involved in the production of carotenoids starting from the production of
isoprenoid precursors.
2. GENERATION OF C5 ISOPRENOID PRECURSORS
Carotenoids are tetraterpenes derived through the condensation of the five-carbon (C5)
universal isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl
pdiphosphate (DMAPP). Two pathways responsible for the synthesis of isoprenoid
precursors IPP and DMAPP exist in nature. The acetate-mevalonate (MVA) pathway,
originally described by Block, Lynen, Popjak and others, 22 is associated with the
production of isoprenoids in animals and yeast and till the late 1990’s was considered to be
only source of isoprenoid precursors for terpenoid synthesis including carotenoids. 23
Several early attempts to trace the fate of labeled acetate in forming lycopene, hopanoids,
taxol and sterols revealed differences in distribution of the label within the basic isoprene
unit inconsistent with a single source of isoprenoid precursors for all terpenoids. 24 These
results led to the discovery by several independent research groups of a mevalonate-
independent pathway in eubacteria, 25 green algae 26 and higher plants. 24c,27 The studies of
the labeling pattern of ubiquinone following incorporation of 13C-labeled glycerol or
pyruvate allowed Rohmer et al. to identify the conversion of pyruvate to 1-deoxy-D-
xylulose-5-phosphate (DXP) as the first step of the mevalonate-independent pathway. 28 In
independent studies, by tracing the fate of [1-13C]- and [2,3,4,5-13C4]-DXP in the labeling
pattern of β-carotene, lutein, phytol and sitosterol in cell cultures of Catharanthus roseus,
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Arigoni et al. demonstrated unequivocally the involvement of DXP in the non-mevalonate
pathway, also known as the 2C-methyl-D-erythritol-4-phosphate (MEP) pathway and
provided further insight in the compartmentalization of isoprenoid synthesis. 29
Furthermore, the studies by Arigoni et al described the occurrence of an intramolecular
skeletal rearrangement in the formation of isoprenoid precursors through the non-
mevalonate pathway as first proposed by Eisenreich et al.. 24c
Isoprenoid precursors are generated by all organisms with the possible exception of obligate
intracellular organisms such as rickettsiae and mycoplasmas. The MEP pathway is utilized
by the great majority of eubacteria including photosynthetic cyanobacteria, algae and by all
Apicomplexan protists including parasitic pathogens such as Plasmodium falciparum and
Toxoplasma gondii. 30 Archaebacteria, fungi and animals derive isoprenoids strictly via the
MVA pathway. 31,32 While most carotenogenic organisms use either the MEP or the MVA
pathway to produce IPP and DMAPP, plants and a few bacterial Streptomyces species
generate isoprenoid precursors using both the MVA and the MEP pathway. 33 The cytosolic
(MVA-derived) and plastidial (MEP-derived) plant isoprenoids, however, have different
biological fates; plant carotenoids are derived predominantly from isoprenoid precursors
generated via the MEP pathway. 27b There is evidence of limited exchange of isoprenoid
precursors as well as higher intermediates between the two plant cell compartments. 34 For
example, in the case of carotenoids synthesized by the unicellular alga Euglena, carotenoids
were derived from both the MVA and MEP pathway. 35 However, neither the MVA nor the
MEP pathway can successfully compensate for the absence of the other. Figure 1 illustrates
the fate of the radiolabel from [1-13C]–glucose in the formation of isoprenoid units via either
the MVA or the more recently discovered MEP pathway.
2.1 The 2C-methyl-D-erythritol-4-phosphate-MEP pathway
It is believed that the MEP pathway initially developed in a specific clade of eubacteria and
spread through horizontal transmission to other (eu)bacteria. The origin of the MEP pathway
in eukaryotes, i.e. plants, is attributed to an ancestral cyanobacterial endosymbiont, which
later evolved into plastids. 36 During the course of evolution the genes coding for enzymes
involved in the MEP pathway have become integrated by the host nucleus and the enzymes
evolved to be post-translationally targeted to plastids via a plastidial targeting sequence. 37
Ancestors of apicomplexan protists also acquired a plastid known as an apicoplast from a
red algal endosymbiont. 38 As a result, the MEP pathway is the sole source of isoprenoids in
important pathogenic protists such as Toxoplasma gondii 18b and Plasmodium falciparum
and thus the protozoan MEP pathway represents a promising pharmacological target. The
MEP pathway from plants and eubacteria is illustrated in Fig. 2 and shown in comparison
with the MVA pathway.
2.1.1 Synthesis of 1-deoxy-D-xylulose-5-phosphate—The enzyme 1-deoxy-D-
xylulose-5-phosphate (DXP) synthase, or DXS, catalyzes the condensation of
glyceraldehyde-3-phosphate (G3P) and (hydroxyethyl)thiamine diphosphate derived from
decarboxylation of pyruvate to produce DXP. G3P and pyruvate are derived from the
metabolism of glucose via glycolysis, glyoxylate or the Entner-Doudoroff pathways. 39 The
reaction catalyzed by DXS is the rate-limiting reaction in the MEP pathway. 40 Thus
changes in the expression of DXS in plants 40b and bacteria 40a,41 translate directly to
changes in the levels of isoprenoids produced. DXS from E. coli 42 and higher plants 43 have
been cloned and functionally characterized.
DXS was identified through its sequence similarity to pyruvate decarboxylase and
transketolases which act on similar substrates and catalyze a similar reaction. 42–43 Like
transketolases and pyruvate decarboxylase, DXS is a thiamine diphosphate (TPP)-dependent
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enzyme. 42–43 The reaction mechanism of DXS was proposed to proceed through an ordered
ping-pong mechanism 44 via formation of a reactive TPP ylide to attack pyruvate. Following
decarboxylation, the DXS-α-carbanion intermediate binds G3P resulting in the elimination
of DXP and recycling of the enzyme. 44 Steady-state kinetic studies, inhibition studies, and
CO2-trapping experiments of heterologously expressed and purified DXS from Rhodobacter
capsulatus demonstrated that G3P is required for the decarboxylation of pyruvate and for the
formation of a ternary complex. 44 More recent studies have led others to suggest that DXS
uses a random sequential mechanism through reversible rapid binding of substrates. 45
Analysis of the structures of DXS enzymes from E. coli and Deinococcus radiodurans
revealed interesting differences between the structure of DXS, transketolases and pyruvate
dehydrogenases. 46 While the active site of transketolases and pyruvate dehydrogenase is
found at the interface between two monomers, the active site of DXS is located within the
same monomer along with the binding site for TPP and Mg2+. The structure of DXS
revealed that Glu370 and Arg398 are essential for catalysis and that several other polar
residues are involved in binding substrate and diphosphate. 46 The mechanism of reaction,
structure and key features of DXS in comparison with transketolase are illustrated in Fig. 3
DXS carries out a rate-limiting step in the production of isoprenoid precursors leading to a
multitude of important plastidial-derived terpenoid metabolites. 40b,47 Taking into
consideration the different roles of such terpenoids, it is perhaps not surprising, that plants
code for multiple DXS isoforms which generate precursors destined for various biological
fates. It is also important to note that the various DXS isoforms are expressed in different
tissues and are differentially regulated. 48 In addition to isoprenoids, DXP can be converted
to other essential metabolites such as pyridoxol phosphate and TPP. Therefore, DXS
represents a nodal point in the synthesis of vitamin B1, B6 in addition to isoprenoids.
Of the three DXS isoforms found in maize, 48a,49 DXS1 plays a role in the constitutive
production of isoprenoid precursors as demonstrated by the albino or “cloroplastos
alterados” (cla) phenotype of the A. thaliana plants deficient in this enzyme. 50 On the other
hand, DXS2 and DXS3 are important in iso-prenoid production during specific temporal and
developmental windows. In the case of DXS3, its expression is strongly correlated with the
increase in the levels of carotenoids in endosperm. 49 Conversely, the expression of DXS2
correlates with carotenoid accumulation in plant roots colonized by arbuscular mycorrhizal
fungi. 48a
The regulatory mechanisms that govern the expression of the various DXS isoforms have
not been elucidated. There is evidence that induction of the expression of phytoene synthase
(PSY) enhances the expression 51 and activity of DXS. 52 Therefore, the activity of PSY, an
enzyme committed to carotenoid synthesis, can influence the expression of DXS and thus
the availability of the universal carotenoid precursors IPP and DMAPP. The expression of
DXS can also be upregulated through a post-transcriptional mechanism in response to a
block in the MEP pathway. 53
In addition to the DXS1 (encoded by the CLA1 gene) there are several DXS-related proteins
encoded by the A. thaliana genome which evolved through gene duplication. 54 Though it is
possible that some of the novel DXS-like proteins from A. thaliana contribute to isoprenoid
production, it is also possible that they have evolved to aquire additional enzymatic roles
beyond DXP synthesis.
Evidence derived from multiple studies suggests that there is limited import of cytosolic
isoprenoid precursors or intermediates by plastids. As demonstrated by the lack of
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carotenoids in plants deficient in DXS, 50 cytosolic isoprenoids derived via the MVA
pathway cannot fully compensate for the lack of plastidial isoprenoids.
2.1.2 Conversion of 1-deoxy-D-xylulose-5-phosphate to 2C-methyl-D-
erythritol-4-phosphate—Analysis of the fate of 13C-labeled glucose in isoprenoid
metabolites revealed that the labeling pattern of menaquinones by Corynebacterium
ammoniagenes is identical to that observed in the case of MEP. This observation implicated
MEP as the second metabolite of what became know as the MEP pathway. 55 By screening
for E. coli mutants that display 2C-methyl-D-erythritol auxotrophy, Kuzuyama et al.
identified 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) as the enzyme
responsible for the synthesis of MEP. 56
DXR catalyzes the first committed step of the MEP pathway towards isoprenoid synthesis.
DXR carries out the ordered intramolecular rearrangement of DXP and subsequent reduction
to produce MEP in the presence of NADPH and a divalent metal ion. 56b,57 Initially
proposed to undergo an alpha-ketol rearrangement, the intramolecular rearrangement of
DXP catalyzed by DXR is more recently thought to occur through a retroaldol/aldol
mechanism based on the measurement of the kinetic isotope effect using [3-2H]- and [4-2H]-
DXP. 58 Thus deprotonation of the C4 hydroxyl group is followed by a rate-limiting step of
cleavage of the 3–4 bond of DXP to hydroxyacetone and glycoaldehyde phosphate. This is
followed by aldol condensation to produce 2C-methyl-D-erythritose-4-phosphate. Next,
DXR catalyzes the reduction of 2C-methyl-D-erythritose-4-phosphate using NADPH to
form MEP. Studies of the stereo-specificity of the reaction using recombinant DXR protein
of E. coli and of the cyanobacteria Synechocystis sp. strain PCC6803, revealed that DXR
transfers the pro-S hydrogen from the si face of NADPH to the re face of the aldehyde. 59
The importance of DXR in the formation of carotenoids is underscored by the powerful
inhibitory effect of the antimalarial drug 3-[formyl(hydroxy)amino]propylphosphonic acid
(fosmidomycin), 30b a specific inhibitor of DXR, 56a on carotenoid accumulation in ripening
tomatoes. 60
Numerous crystal and one NMR structure of DXR from bacterial and protozoan pathogens
have been reported. 61 DXR functions as a homodimer, each monomer containing separate
active sites. Highly conserved residues participate in hydrogen bonding to the phosphate
group and in coordinating the required divalent metal ion. Structural studies of apo and
inhibitor-bound DXR reveal an induced fit model of substrate binding which rely on a
flexible “lid” loop that closes upon binding substrate. 61a,b The mechanism of reaction,
structure and key features of DXR are illustrated in Fig. 4.
In addition to DXR, there are other enzymes shown to catalyze the conversion of DXP to
MEP which bear no sequence similarity to DXR. This DXR-independent activity is carried
out by enzymes found only in bacteria and referred to as DXR-like (DRL). 62 Some species
of bacteria like Brucella abortus and Mesorhizobium loti only code for DRL enzymes while
others code for both DXR and DRL. Importantly, Roseobacter litoralis, which is known to
synthesize carotenoids, codes for a DRL enzyme which was shown to be functional in
complementation assays. 62 R. litoralis also codes for a DXR-type enzyme, however, this
enzyme is not active in complementation assays. 62 Presumably in the case of R. litoralis
carotenoid synthesis relies solely on the activity of DRL for the formation of isoprenoid
precursors. The, distribution, evolutionary history and role of DRL enzymes is relevant for
evaluating the potential of targeting enzymes of the MEP pathway for drug discovery.
Though DRL enzymes are sensitive to fosmidomycin, several reported structures show only
distant structural similarity to DXR. 62 Intriguingly, DRL enzymes which complement
DXR-deficient E. coli strains can also be found in bacteria which only utilize the MVA
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pathway for isoprenoid synthesis and lack all other MEP pathway genes; this observation
suggests that some DRL enzymes might have aquired additional enzymatic roles. 63,64
It was reported by Ershov et al. that isoprenoid synthesis in the cyanobacterium
Synechocystis strain PCC 6803 grown under photosynthetic conditions is not susceptible to
inhibition by fosmidomycin and that isoprenoid production in Synechocystis can be
stimulated by substrates derived from the pentose phosphate pathway but not by MEP
substrates such as pyruvate or DXP. 65 In addition, it was shown that isoprenoid production
stimulated by pentose phosphate cycle substrates in Synechocystis requires the activity of the
product of the sll1556 gene, which codes for an isopentenyl diphosphate isomerase type 2
(IDI-2). 66 These findings argue that there might be alternate routes for isoprenoid
production that bypass MEP, perhaps derived from the pentose phosphate cycle, and which
feed into the late steps of the MEP pathway. However, more studies are needed to
demonstrate the existence of a DXR-independent MEP pathway as neither the intermediates
nor the enzymes involved in this proposed shunt have been characterized.
2.1.3 Conversion of 2C-methyl-D-erythritol-4-phosphate to 2C-methyl-D-
erythritol-2,4-cyclodiphosphate—Radiolabeled MEP incubated with E. coli extracts
becomes converted to the nucleoside derivative 4-4-(cytidine 5′-diphospho)-2C-methyl-D-
erythritol (CDP-ME). In turn, radiolabeled [2–14C]CDP-ME incubated with chromoplasts
becomes incorporated in the carotenoid fraction demonstrating the involvement of CDP-ME
in the MEP pathway for isoprenoid synthesis. 67 Based on these observations, Rohdich et al.
used a bioinformatics approach to look for unannotated proteins with similarity to ribulose
5-phosphate reductase/CDP-ribitol pyrophosphorylase which carries out a very similar
reaction to the MEP → CDP-ME transformation. These studies led them to identify the gene
IspD of E. coli which codes for 2C-methyl-D-erythritol-4-phosphate cytidyltransferase
(MCT), the fourth enzyme of the MEP pathway. 67
Structures of both bacterial 68 and plant MCT 69 have been reported. MCT assumes a
dimeric conformation and each subunit of the functional MCT dimer features a globular
domain and an extended β-sheet arm. 68a,69a The two subunits of the MCT dimer are held
together by the interlocked β-sheet arms. The two active sites of the dimer involve residues
derived from both monomers. A divalent metal ion which is essential for the
cytidyltransferase activity of purified E. coli MCT, interacts with the α-, β- and γ-phosphate
oxygens of the substrate CTP and the α-phosphate oxygen of the CDP-ME product. 68a The
active sites reside at the interface of the subunits. It is still unclear which residues of MCT
participate in the coordination of the metal ion. Comparison of the A. thaliana and E. coli
MCT reveals differences in the quaternary structure but the two structures are relatively
similar. 69a The mechanism of reaction, structure and key features of MCT are illustrated in
Fig. 4.
Similar approaches to the one used by Rohdich to identify IspD, 67 led to the discovery of
the next two enzymes of the MEP pathway. 70 Accordingly, CDP-ME is converted by CDP-
ME kinase (CMK) to 4-(cytidine 5′-diphospho)-2C-methyl-D-erythritol-2-phosphate (CDP-
ME-2P) which in turn is converted through an intramolecular transphosphorylation to 2C-
methyl-D-erythritol-2,4-cyclodiphosphate (MECDP) by MECDP synthase (MDS).
Radiolabeled CDP-ME-2P and MECDP are efficiently incorporated into carotenoids by
isolated chromoplasts from Capsicum annuum demonstrating their involvement in the MEP
pathway. 70–71 Deleterious mutations in genes coding for enzymes involved in the MEP
pathway are not viable in E. coli which made genetic attempts at generating MEP pathway
mutants in this organism futile. By engineering E. coli to also produce IPP using the MVA
pathway, however, one can maintain strains deficient in various MEP pathway genes on
media supplemented with MVA. This elegant approach was employed by several groups to
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provide definite genetic proof of the involvement of candidate genes in the main trunk of the
MEP pathway. 72
Structure analysis of CMK from several bacterial species indicates the enzyme forms a
homodimer of subunits that interact weakly and which surround a large central channel. 73
Each subunit of CMK displays the alpha/beta fold characteristic of the Galacto-,
Homoserine-, Mevalonate-, Phosphomevalonate-kinase (GHMP) superfamily 73a,74 and
each subunit contains a complete active site including an ATP binding domain. None of the
reported structures of CMK indicate an associated metal ion, though a divalent metal ion
was shown to be required for the activity of purified tomato CMK. 75
Reported structures of MDS from bacterial 76 protozoan and plant species 77 reveal a well
conserved fold consisting of a homotrimeric protein surrounding a central cavity. The
proposed mechanism of reaction of MDS involves an in-line attack on the β-phosphate. A
metal ion is required to stabilize a presumed pentacoordinate transition state. 76a While both
Zn2+ and Mg2+ were found bound to bacterial MDS and are required for catalysis, 76a only
one divalent ion was reported in the structure of plant MDS. 77 The three active sites of
MDS are located at the interfaces of the subunits. The mechanism of reaction, structure and
key features of CMK and MDS are illustrated in Fig. 5.
2.1.5 Synthesis of isopentenyl diphosphate and dimethylallyl diphosphate—
Bioinformatics and genetic approaches led to the identification of two more bacterial genes
IspG and IspH coding for 1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate (HMBPP)
synthase (HDS) and HMBPP reductase (HDR), respectively, the last enzymes of the MEP
pathway. HDS and HDR were identified as essential for isoprenoid production via the MEP
pathway in E. coli engineered to produce isoprenoids from MVA, 72b–d in the
cyanobacterium Synechocystis 78 and in plants. 53 Overexpression of HDS in addition to
DXR, MCT, CMK and MDS conferred cells the ability to produce HMBPP, the final
intermediate of the MEP pathway. 79 Conversely, deletion of HDR led to the accumulation
of HMBPP in E. coli. 80 Overexpression of HDR in addition to DXR, MCT, CMK, MDS
and HDS in the presence of D-xylulokinase and 1-deoxy-D-xylulose led to production of the
universal C5 isoprenoid precursors IPP and DMAPP in a ratio of 5:1. 81 Thus successful
reconstitution of the MEP pathway downstream of DXS provided conclusive evidence that
the complete set of enzymes involved in the main trunk of the MEP pathway have been
identified.
Analysis of the purified HDS and HDR proteins by UV/visible, iron content determination
and electron paramagnetic resonance (EPR) spectroscopy indicate that these enzymes
possesses a dioxygen-sensitive [4Fe-4S] cluster. 82 Purified HDS and HDR are easily
inactivated by oxygen but regain activity upon reconstitution of the iron-sulfur
cluster 82b,c,e,83 and in the presence of a reducing system such as the flavodoxin/ flavodoxin
reductase in bacteria 82b,c or ferredoxin in plants and cyanobacteria. 82d,84 Both flavodoxin
and an A-type Fe-S protein which transfers the [4Fe–4S]2+ cluster to HDS apoprotein are
required for the functioning of the MEP pathway in bacteria. 85 The mechanism of HDS and
HDR is proposed to involve organometallic species: “metallacycles” in the form of (η(2)-
alkenes) and η(1)/η(3)-allyls. 86 The mechanism of reaction, structure and key features of
HDS and HDR are illustrated in Fig. 6.
Analysis of the structure of several apo and holo-HDS from bacterial species 87 indicates
HDS assumes a dimer conformation. Two structural domains compose each subunit. The N-
domain is an eight-stranded β-barrel globular domain with similarity to the a common (βα)8-
fold adopted by members of the triose phosphate isomerase (TIM) barrel superfamily. The
C-domain harbors three cysteines and one glutamate residue which coordinate the [4Fe-4S]
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cluster. 87a Binding of MECDP to the active site formed by the N-domain of one subunit and
the C-domain of the other subunit leads to a substrate-induced rearrangement of the C-
terminal domain as seen in the structure of the HDS holoprotein 87c and also shown by EPR
measurements. 86b Plant HDS contain a third structural domain between the domains
homologous to the N- and C-domains of bacterial HDS. The plant specific HDS domain is
proposed to form a TIM-barrel structure that plays a primarily structural role. 87b
The structures of several bacterial HDR proteins have been reported and HDR. 87c,88 HDR
is a dimer of two cloverleaf like subunits 88a,b The subunits are distinguished by three
structurally similar domains surrounding a central cavity which contains the [4F-4S] cluster
and the active site 88c The structure of HMBPP-bound HDR indicates that the substrate is
presented in a cyclic conformation and forms a complex with the apical iron of the [4F-4S]
cluster. 88c,d Mössbauer spectroscopic studies also indicate that the apical iron of the HDR
[4F-4S] cluster exhibits an unusual coordination to several additional O and/or N atoms in
addition to three sulfur atoms of the [4F-4S] cluster. 82e,89 Analogues of HMBPP which
replace the OH group with poorer leaving groups such as thiol or amino, coordinate to the
apical iron group and are potent inhibitors of HDR. 89–90
The mechanism of reduction of HMBPP by HDR proceeds through a sequential reaction of
two electron transfer from HDR to substrate. The first electron transfer generates an allyl
radical. Transfer of a second electron allows the formation of an allyl carbanion
intermediate 88c,d Protonation of either C3 or C1 affords IPP or DMAPP, respectively. 88d
Binding of substrate induces the closure of the active site and elimination of solvent to
prevent hydrolysis of the diphosphate ester. 88c,d In addition to its role in the reductive
dehydroxylation of HMBPP, HDR can also catalyze the addition of water to acetylenes to
form ketones and aldehydes via anti-Markovnikov / Markovnikov addition. 91
There is evidence that the enzymes of the MEP pathway and carotenoid synthetic enzymes
in general associate in multienzyme complexes which are membrane bound in some
cases. 68c,92 The role of a multienzyme complex could be to facilitate substrate channeling
and prevent the loss of intermediates through side reactions.
2.2 The Mevalonate Pathway
The MVA pathway has evolved in archaea to provide precursors for the synthesis of
isoprenoid constituents of the 2,3-dialkyl-glycerol lipids. The pathway contributes to
carotenoids production primarily in archaea and fungi and rarely in eubacteria. 93 Based on
the species distribution and the compartmentalized nature of isoprenoid metabolism in
plants, the bulk of precursors for carotenoid synthesis in nature derive from the MEP
pathway. Yet, there is limited exchange of metabolites between cytosol and plastids, hence,
the MVA pathway can also contribute to a percentage of carotenoids produced in species
that utilize the MEP pathway. Knowledge of the genes involved and regulation of the MVA
pathway is also an important consideration for the engineering of carotenogenic pathways in
heterologous systems or hosts. 94 The MVA pathway from metazoa and fungi and a
variation of the pathway found in archaea are illustrated in Fig. 2.
The specifics of the MVA pathway have been elucidated by an elegant series of labeling
experiments by Bloch and Lynen among others investigating the synthesis of isoprenoids in
animals and fungi (reviewed in Goodwin and in Beytia and Porter 95). Though the MVA
pathway has been described many years ago, more details are still emerging particularly in
the structural understanding of the biochemical details of the MVA pathway and the
development of pharmacological inhibitors in the treatment of hypercholesterolemia. In the
first step of the MVA pathway two acetyl CoA molecules undergo a Claisen condensation to
produce acetoacetylCoA in a reaction catalyzed by acetoacetyl CoA thiolase (AACT).
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Addition of a third acetyl CoA molecule is catalyzed by 3-hydroxyl-3-methylglutaryl CoA
synthase (HMGS) yielding 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) which reduced to
MVA by HMG-CoA reductase (HMGR). MVA is sequentially phosphorylated by
mevalonate kinase (MK) to produce mevalonate-5-phosphate (MVA-P) and then by
phosphomevalonate kinase (PMK) to produce mevalonate-5-diphosphate (MVA-PP).
Subsequent phosphorylation/dephosphorylation allows the decarboxylation and elimination
of phosphate to produce isopentenyl diphosphate (IPP) by mevalonate diphosphate
decarboxylase (MVD).
As most archaea lack PMK and MVD, 96 it was proposed that they utilize an alternate route
to produce IPP from MVA-P by undergoing first decarboxylation to produce isopentenyl
phosphate (IP) followed by phosphorylation of IP to IPP by an IP kinase. 97 The structure of
the archaeal IP kinase indicates it belongs to the amino acid kinase family. 98 Mevalonate
decarboxylation reaction is proposed to proceed through phosphorylation and formation of a
carbocation transition state. 99 Several archaeal gene sequences with similarity to
mevalonate kinase were proposed to code for the MVD enzyme, 100 however, the activities
of the putative archaeal MVD have not been verified experimentally.
2.3 Interconversion of isopentenyl diphosphate and dimethylallyl diphosphate
Since HDR can synthesize a mixture of both IPP and DMAPP, it is not essential for
organisms which can utilize the MEP pathway to be able to interconvert these two
isoprenoid precursors. However, IPP-DMAPP isomerase (IDI) activity is indispensable in
the formation of DMAPP in animals, archaea and fungi which are restricted to using the
MVA pathway. Isomerization of IPP is catalyzed by two very different classes of IDI
enzymes which have evolved separately and have different phylogenetic distribution
(reviewed in 101).
Members of the IDI type 1 (IDI-1) enzyme family are found in most species except for some
archaea and eubacteria. 102 IDI-1 enzymes originally discovered by Lynen et al. 103 and
cloned by Hahn et al. require Zn2+ and Mg2+ for catalysis. 104 The mechanism of IDI-1
catalyzed isomerization of IPP to DMAPP is thought to occur through the protonation of
substrate and deprotonation of the tertiary carbocation intermediate in a reaction facilitated
by Zn2+ or Mn2+. 105 A second divalent metal ion, most likely Mg2+, plays a role in binding
substrate. 105d In eukaryotes different isoforms of IDI-1 are targeted to various cellular
locations such as plastids, mitochondria or peroxisomes where they contribute to the
synthesis of isoprenoids in the respective compartment. In the case of tobacco plants and A.
thaliana, only one of the two IDI-1 isoforms present becomes targeted to the plastids. 106
Maize IDI-1 contributes to light-stimulated carotenoid synthesis. 107 However, ablation of
either or both the plastidial or mitochondrial IDI-1 isoforms in A. thaliana activity results in
no or very modest reduction in carotenoid synthesis, which is most likely as a result of a
secondary metabolic effect. 106b,108 These results would argue that IDI-1 mediated
interconversion of IPP and DMAPP plays a limited role in organisms utilizing the MEP
pathway.
The structure of several bacterial and human IDI-1 have been reported. 105e,109 IDI-1 acts as
a monomer and assumes a compact globular α/β fold. Human IDI-1 undergoes a
conformational change upon substrate binding. 105e The active site of human IDI-1 contains
a glutamate (Glu148) and a tyrosine (Tyr136) residue on one side and a cysteine (Cys86)
residue positioned on opposite sides of the substrate. The stereoselective antarafacial
reaction proceeds through an acid (glutamate) catalyzed protonation; formation of a tertiary
carbocation intermediate; deprotonation by a nucleophile (cysteine) and formation of a
double bond. 105d,e,109a A tryptophan residue stabilizes the carbocation intermediate through
π-interactions 109a
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IDI type 2 (IDI-2) enzymes are found in archaea, proteobacteria 102 and cyanobacteria
Synechocystis sp. strain 6803. 66,110 IDI-2 is often associated with carotenogenic gene
clusters in Enterobacteriaceae and Pantoea species (formerly Erwinia). 111 IDI-2 is a
flavoprotein 112 which requires reduced FMN and NADPH to catalyze an isomerization
reaction which involves no net redox change. 113 Structural studies of IDI-2 indicate it
assumes a homooctameric configuration in solution 110a and in several crystal forms. 114
The IDI-2 octamer dissociates into tetramers upon substrate binding. 114c
Overexpression of IDI-2 plays an important role in bioengineering E. coli to produce
carotenoids. E. coli utilize the MEP pathway for isoprenoid production and code for an
IDI-1 but do not produce carotenoids as they lack the enzymes associates with the later
steps. Heterologous expression of carotenogenic genes in E. coli can result in production of
carotenoids. It was observed that despite the presence of the MEP pathway and despite the
presence of a native IDI-1, inclusion of IDI-2 in the carotenogenic gene cluster transformed
in E. coli results in a dramatic increase in the levels of carotenoids produced 111 The
structures and key features of IDI-1 and IDI-2 are illustrated in Fig. 6.
The mechanism of reaction of IDI-2 involves protonation and deprotonation reaction
mediated by reduced FMN which in this case functions as an acid/base catalyst. 115 Based
on the crystal structure of IDI-2 bound to inhibitors it has been proposed that the proton
transfer to substrate involves the N5 proton of FMN. 116 Accordingly, EPR analysis and use
of radical clock probes did not detect the presence of a substrate radical-flavin radical
pair; 115a,c,d meanwhile, purified Sulfolobus shibatae IDI-2 is not active if reconstituted with
5-deaza-analog of FMN. 113 The mechanism proposed for IDI-2 is the first example of the
utilization of reduced FMN in in acid-base catalysis by an enzyme. 115d,e,g,116b Importantly,
several other enzymes involved in carotene synthesis, such as lycopene cyclase, CrtY, 117
and carotene isomerase, CRTISO, 118 depend on reduced flavin moieties to catalyze
reactions without concomitant change in the net redox state of the reaction.
3. LYCOPENE SYNTHESIS
3.1 Synthesis of phytoene
Phytoene synthesis represents the first committed step in the production of carotenoids and it
is considered as the rate-controlling reaction in the pathway. 51b,92e,119 Phytoene is a C40
isoprenoid generated through the head-to-head 1–1 condensation of two molecules of
geranylgeranyl diphosphate (GGPP) to produce first prephytoene and then phytoene. GGPP
in turn is generated by the condensation of IPP and DMAPP. Phytoene synthesis is
illustrated in Fig. 7.
Three IPP’s and one DMAPP molecule undergo 1′-4 head-to-tail condensation to form the
C20 iso-prenoid product geranylgeranyl diphosphate in a reaction catalyzed by GGPP
synthase (GGPPS). GGPPS was first identified in carotenogenic bacteria Pantoea
agglomerans (formerly Erwinia herbicola 120 and plants 121 and later in yeast 122 and
animals 123 (reviewed in Bouvier et al. 124). There are multiple GGPPS enzyme isoforms in
plants most of which are plastid located. 125 GGPP is a key intermediate in isoprenoid
metabolism of plants, as a precursor of carotenoids, tocopherols, side chain of chlorophylls,
plastoquinones and the phytohormones gibberlins. The diverse functions and regulations of
these iso-prenoids make the presence of multiple GGPPS isoforms in plants necessary.
Different GGPPS isoforms and GGPPS from different organisms vary with regards to the
preference for starting allylic substrate. Some plant GGPPS use primarily DMAPP while
animals and fungi GGPPS prefer farnesyl diphophosphate (FPP). 124
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The sequence of GGPPS enzymes indicates the presence of aspartate-rich, DDxx(xx)D,
motifs characteristic of trans-prenyltransferases that are involved in the coordination of a
Mg2+ cluster used in substrate binding and catalysis. 126 The 1′-4 coupling reaction
catalyzed by GGPPS occurs via nucleophilic attack of the olefinic double bond of IPP onto
the carbocation formed through release of the allylic di-phosphate group (DMAPP, GPP or
FPP). 127 GGPP is generated through three cycles of ionization-condensation-elimination
reaction in which one additional IPP (C5 isoprenoid) unit is added at a time. 128 While FPP
synthase (FPPS) limits chain elongation through the presence of a bulky residue before the
first DDxx(xx)D motif at the end of the reaction cavity, 129 yeast GGPPS use alternate
determinants of chain length. 130
Several structures of ligand-bound and free GGPPS from yeast, 130,131 human 132 and one
plant species have been reported. 133 The plant GGPPS from Sinapis alba was crystallized
bound to GGPP obtained fortuitously from the bacterial host. Each subunit of the GGPPS
dimer adopts a predominantly α-helical fold also seen in FPPS and other trans-
prenyltransferases. The structure of GGPPS indicates that a Mg2+ cluster mediates binding
of the allylic substrate while IPP binds to a second (homoallylic) binding site composed of
positively charged residues. 127,130b In addition to the diphosphate binding sites, both
substrates can interact with two distinct hydrophobic binding sites. 132,134 Identification of
GGPP bound to the allylic site of GGPPS offers an explanation for the regulation of GGPPS
by GGPP through a negative feedback mechanism. 132 The mechanism of cyclic
condensations, structure and key features of GGPPS are illustrated in Fig. 8.
Phytoene synthase (PSY) catalyzes the head-to-head condensation of two molecules of
GGPP. PSY was initially purified and its gene cloned from plants 135 and bacteria. 136 Later
studies showed that PSY is found exclusively in carotenogenic organisms. PSY catalyzes an
important rate-controlling step in the synthesis of carotenoids, 119 as a result, its levels are
highly regulated at both transcriptional and post-transcriptional level. 137 Some plant species
code for several paralogs of PSY that are differentially regulated and have different tissue
and intracellular expression patterns. 92e,137b,c,138 Importantly, the expression of PSY is
upregulated in response to accumulation of downstream intermediates of the poly-cis
pathway. 139 This is reminiscent of the upregulation of DXS in response to a block in the
MEP pathway. 53
Consistent with the role of carotenoids in photoprotection, the expression of PSY in A.
thaliana is also upregulated in response to an increase of red and farred
illumination. 137b,138c,d,140 The phytochrome interacting factor 1 (PIF1) that represses the
expression of PSY is rapidly degraded by photoactivated phytochromes in response to
light. 141 This effect results in the derepression of PSY and an increase in carotenoid
production. Other carotenogenic and plastidial genes are regulated by PIF-like transcription
factors in response to developmental and environmental stimuli. 142
Despite lack of structural models of PSY, much can be deduced about its activity based on
its similarity to dehydrosqualene (4–4′-diapophytoene) synthase (CrtM) and squalene
synthase (SQase) which have been structurally characterized. CrtM, is a bacterial enzyme
related to PSY which catalyzes the head to head condensation of FPP to generate 15-cis-
dehydrosqualene, a C30 isoprenoid. Dehy-drosqualene is a precursor for the synthesis of the
C30 class of carotenoids, staphyloxanthins, produced by the human pathogen S. aureus. The
reaction mechanism employed by CrtM is very similar to the one employed by PSY, as the
two enzyme share very similar substrates and intermediates. In fact, a heterologous
expression system which combines GGPPS, CrtM and the bacterial phytoene desaturase
CRTI in E. coli can lead to the production of trace amounts of lycopene in such host. 143
Random mutagenesis led to the identification of several mutants of CrtM which, like PSY,
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display increased preference for the synthesis of C40 carotenoid products 143 The enzymatic
reaction, structure and key features of CrtM are illustrated in Fig. 9 along with a prediction
of the structure of PSY based on based on multiple threading alignments and iterative
threading assembly refinement (I-TASSER). 144
Detailed mechanistic studies and several structures of free and ligand-bound CrtM and
SQase have illustrated the key features of the head-to-head terpene cyclase reactions. The
structure of CrtM bound to FFPP substrate indicates a typical isoprenoid fold with two
distinct substrate binding sites for the allylic donor FFPP and the prenyl acceptor FFPP,
respectively. 145 The diphosphate group of the prenyl donor interacts with a divalent metal
ion cluster, which is coordinated to DXXXD motifs. 145–146
The head-to-head terpene condensation proceeds through an ordered reaction which begins
with the ionization of the donor GGPP through abstraction of diphosphate to form a
geranylgeranyl carbocation. This is followed by nucleophilic attack by the acceptor GGPP to
produce prephytoene, a stable cyclo-propylcarbinyl disphosphate intermediate, with a 1′-2–3
structure. 147 Similarly to SQase, PSY and CrtM catalyze a complex rearrangement of the
1′-2–3 cyclopropylcarbinyl diphosphate intermediate via a c1′-2–3+ → c1′-1–2+
cyclopropylcarbinyl – cyclopropylcarbinyl rearrangement. In the case of PSY and CrtM, the
rearrangement is followed by loss of proton and the formation of the 1–1′ product 15-cis-
phytoene or 15-cis-dehydrosqualene, respectively. 148 In contrast, SQase requires NADPH
in controlling the stereochemistry of the reaction and to catalyze a further reduction with
inversion of configuration of 15-cis-dehydrosqualene which affords squalene. 148–149
3.2 Lycopene synthesis in fungi and bacteria
Two distinct pathways allow for the formation of all-trans-lycopene from phytoene. One
pathway present in all carotenogenic bacteria with the exception of cyanobacteria relies on
one single enzyme, the bacterial-type phytoene desaturase (CRTI), to carry out the
desaturation of four bonds of phytoene at position 7, 11, 11′ and 7′. A second pathway
present in cyanobacteria, green algae and plants relies on four enzymes, to carry out the
same process. The CRTI-based pathway lycopene synthesis pathway found in most
carotenogenic bacteria except cyanobacteria is illustrated in Fig. 7.
Screening for mutations leading to carotenoid deficiency in the nonsulfur purple
photosynthetic bacteria Rhodobacter capsulatus led to the indentification of bacterial-type
phytoene desaturase, CRTI. 150 The CRTI enzyme was later purified and shown to require
FAD as a cofactor and oxygen (aerobic) or quinones (anaerobic) as final electron
acceptors. 151135b,151–152 Analysis of its gene sequence and more recently its structure
revealed CRTI bears similarity to protoporphyrinogen oxidoreductases and mono-amine
oxidase. 152c,153 The sequence and structural homology between phytoene desaturases like
CRTI and monoamine and protoporphyrinogen oxygenases extends beyond the canonical
FAD binding domain to include additional conserved residues and structural motifs. 152c,154
The available structure of CRTI is not ligand or cofactor-bound, but it offered hints with
regards to the reaction mechanism of CRTI. In addition to its extended FAD binding
domain, the structure of CRTI also indicates a putative substrate binding domain and a
possible membrane-binding or regulatory domain. 152c There is also evidence of a structural
rearrangement upon cofactor binding based on evidence that FAD binding to reconstituted
CRTI is necessary for its association with membranes. 152c It has been reported that CRTI
catalyzes the desaturation of both ends of the carotenoid molecule simultaneously to
produce predominantly symmetric products such as the ζ-carotene intermediate produced by
desaturation at 11 and 11′ and the final product all-trans-lycopene. 152b However, docking
studies suggest that the ligand binding pocket of CRTI can accommodate only half of the
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carotenoid molecule, 152c which implies that CRTI might function as a dimer to recognize
both ends of the carotenoid molecule simultaneously. More studies are needed to establish
the quaternary structure of the active CRTI enzyme and to identify residues and domains
involved in catalysis and membrane association. The enzymatic reaction, structure and key
features of CRTI are illustrated in Fig. 10.
Based on the analogy of CRTI to monoamine oxidases, the desaturation of phytoene by
CRTI could proceed by one of several different mechanisms involving either 1) direct
hydride transfer from substrate to FAD, 2) single electron transfer, 3) hydrogen transfer or
4) a nucleophilic mechanism. 155 It was proposed that CRTI employs a hydride transfer
mechanism based on the similar α-β dehydrogenation reaction carried out by FAD-
dependent acyl-CoA dehydrogenases. 156 The mechanism of CRTI was probed using a 5-
deaza-FAD analog which lacks the lone electron pair on N5 thus it is restricted to two-
electron transfer chemistry. 157 econstitution of CRTI with 5-deaza-FAD should allow for
the proposed hydride transfer mechanism, 158 yet, CRTI is inactive when reconstituted with
the 5-deaza-FAD. 152c It is possible that in the case of CRTI 5-deaza-FAD does not support
hydride transfer for steric reasons. Other mechanisms of reaction that could be considered
include single-electron transfer through the formation of a radical pair between substrate and
semiquinone as proposed for monoamine oxidase. 159 Another mechanism based solely on
FAD acting as an acid/base catalyst could also be envisioned. This mechanism was first
proposed for IDI-2, 115d,g,116b which is also inactive when reconstituted with 5-deaza-
FAD. 115d More studies are needed to discern between hydride transfer, single-electron
transfer, acid/base, or other potential mechanisms of reaction of CRTI.
It is predicted that in addition to desaturation, CRTI also carries out the isomerization of the
15-cis double bond of phytoene. This is based on the fact that all products of CRTI,
including partially desaturated intermediates such as phytofluene and ζ-carotene, are found
predominantly in the all-trans configuration. 152b Purified CRTI reconstituted with reduced
FAD (FADred) does not isomerize 15-cis-phytoene to all-trans-phytoene when examined in
vitro under anaerobic conditions. 152c However, FA-Dred-CRTI does catalyze the
isomerization of the non-natural substrate tetra-cis lycopene to tri-cis lycopene. 152c
Mechanistic studies of the isomerization of tetra-cis lycopene by FADred-CRTI using D2O
indicate that FADred-CRTI uses an acid-base catalysis mechanism in the isomerization of
tetra-cis lycopene. 117b An alternative proposed mechanism for the CRTI-catalyzed
isomerization reaction suggests that the isomerization of the 15-cis bond occurs concurrently
with the desaturation of adjacent double bonds. 160 In this model formation of the allylic
carbocation intermediate allows the delocalization of the Π-electrons and free rotation of the
15–15′ bond resulting in trans isomerization. 160 More mechanistic studies and especially
high resolution structures of CRTI reconstituted with FAD and substrate are needed to
establish the geometry of the active site and whether any amino acid residues play roles in
the deprotonation of the substrate or in stabilizing the presumed allylic carbocation
intermediate.
CRTI from different species display variability with regards to the number of cycles of
desaturation catalyzed. CRTI from Pantoea ananatis (former Erwinia uredovora) carries out
four successive desaturation cycles of phytoene to produce lycopene. On the other hand,
CRTI from Rhodobacter sphaeroides carries out three desaturation cycles which afford
neurosporene. 161 Several key residues that control the number of cycles of desaturation
were identified. 162 Site-directed mutagenesis of these residues increased the number of
desaturation cycles of the neurosporene-producing CRTI from R. sphaeroides to four and
allowed for the production of lycopene. Further mutations of Erwinia CRTI were identified
which can increase the number of desaturation cycles to six and afford the production of a
3,4,3′,4′-tetradehydrolycopene, a fully conjugated species. 163 Fungal CRTI is structurally
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similar to bacterial CRTI 152a and catalyzes 4 or 5 desaturation steps. Fungal CRTI works
together with the fungal bifunctional PSY/ lycopene cyclase to yield β-carotene or the
monocyclic carotenoid torulene through cyclization of 3,4-didehydrolycopene. 164
Examination of other CRTI-like enzymes also revealed that substrate recognition by CRTI is
not dependent on the length of the polyene chain. CrtN, a homologue of CRTI from S.
aureus, desaturates C30 dehydrosqualene to produce 4,4′-diaponeurosporene. 165 The C30-
directed CrtN and the C40-directed CRTI can substitute for one another to desaturate
substrates that are longer, or respectively shorter, than their natural substrate. 166 It is not
clear how different length polyene chains can be recognized by the same ligand binding
pocket within CRTI or CrtN.
3.3 Lycopene synthesis in cyanobacteria and plants – the poly-CIS pathway
In contrast to the all-trans pathway carried by CRTI, lycopene is generated in plants and
cyanobacteria through a poly-cis pathway. 167 The poly-cis pathway involves successive
dehydrogenations and isomerizations carried out by: two desaturases, the plant-type
phytoene desaturase (PDS) and ζ-carotene desaturase (ZDS), and by two isomerases, 15-cis-
ζ-carotene-isomerase (Z-ISO) and CRTISO. PDS, ZDS and CRTISO recognize only one
half of the carotenoid molecule thus the sequence of desaturation and isomerization
reactions proceeds independently for each half of the carotenoid. The sequence of the
reactions is well established. Reactions carried out by Z-ISO and PDS precede ZDS which
requires substrates with desaturated 11 and 11′ bonds 168 and 15–15′ in trans. 169 The
isomerization reaction carried out by CRTISO is the last reaction since it requires substrates
to have adjacent 7- and 9-cis bonds. 170 Thus for each half of the carotenoid molecule the
sequence of desaturation and isomerization reactions generally proceeds in the order
PDS→Z-ISO→ZDS→CRTISO. 160,169,171 The poly-cis lycopene synthesis pathway from
plants and cyanobacteria is illustrated in Fig. 7.
3.3.1 Desaturases/ TRANS-CIS isomerases—PDS was initially identified in
cyanobacteria as a carotenogenic enzyme target of the bleaching herbicide norflurazon. 172
This was soon followed by cloning a corresponding cDNA from soybean, pepper, tomato
and maize. 173 Evidence derived from the effect of PDS inhibitors and the phenotype of PDS
mutants indicate that PDS is essential for carotenoid synthesis. 174 Heterologous expression
of PDS in E. coli indicates it catalyzes a two step saturation of phytoene into ζ-
carotene. 173c,e PDS requires FAD for activity and is a membrane-bound enzyme based
enzymatic assays of purified enzyme reconsitituted into liposomes in the presence or
absence of redox cofactors. 92b,173b,175 Each cycle of dehydrogenation by PDS generates
two electrons which are transferred via a redox chain 176 to plastoquinone 177 and to
chloroplast terminal oxidase 178 using oxygen as the final acceptor. 179 The importance of
plastoquinone in electron transfer to oxygen from PDS during carotenoid synthesis is
underscored by the deficiency in carotenoid production that characterizes mutants with an
impaired quinone biosynthetic pathway. 171b,177c Several point mutations which confer the
mutant PDS enzymes resistance to norflurazon also affect its catalytic efficiency. 172b,180 It
was proposed that norflurazon inhibits PDS by interfering with quinone cofactor
binding. 181
The activity of ZDS was identified though heterologous expression of a candidate phytoene
desaturase in E. coli strains that accumulate ζ-carotene. 182 ZDS was shown to introduce cis-
double bonds in ζ-carotene at position 7 and 7′. The N-terminal domain of ZDS bears
striking sequence similarity to the FAD-binding domain of L-amino acid oxidases, however,
purified ZDS was shown to be active in the absence of added dinucleotide cofactors. 168
Though ZDS does share significant sequence homology with PDS, it is much more resistant
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(1000-fold) to inhibition by the herbicide norflurazon. 183 Like PDS, the activity of ZDS is
required for carotenoid synthesis in vivo. 184
It is not clear why plants and cyanobacteria employ such an elaborate pathway to achieve
the same goal as other bacteria and fungi can accomplish with a single enzyme. The most
likely explanations for the need of isomerases in the desaturation pathway have to do with
the mechanism of reaction of PDS, ZDS, Z-ISO or CRTISO and possible roles of the cis-
intermediates in regulatory signaling pathways. 139 Unfortunately, still too little is known
about the mechanism of the reaction employed by PDS, ZDS, Z-ISO or CRTISO or the
possible origin of the 7, 9, 9′ and 7′ cis-bonds or the role of cis-intermediates beyond
lycopene synthesis.
It was originally proposed that the 9 and 9′ cis-bonds are not a product of the PDS
desaturation reaction and that they originate from a cis-GGPP precursor 171a or,
alternatively, that they result from a prenyltransferase reaction. 170 However, the main C40
precursor that can be detected in plants is 15-cis phytoene and the presumed 9,15,9′-tri-cis-
phytoene has not been reported in wild type or PDS-deficient plants. Therefore, the cis
bonds are most likely formed during the course of the desaturation reactions catalyzed by
PDS and ZDS, as first suggested by Goodwin and later by Clough and Pattenden. 167c,185
Biochemical analysis of the activity of heterologously expressed PDS and ZDS provided
conclusive evidence of the role of PDS and ZDS in the generation of the 9, 9′ and 7, 7′ cis
bonds. 169
In the current view, the poly-cis pathway proceeds as follows. Desaturation of the 11 and 11′
bonds of phytoene by PDS causes the isomerization of the adjacent 9 and 9′ double bonds
from trans to cis. 186 Though, it is still not clear why this is the case, it is possible that
desaturation by PDS occurs through a similar mechanism as invoked for CRTI. 160
Hydrogen abstraction from C-10 leads to the formation of an allylic radical and
delocalization of Π-electrons allowing free rotation and isomerization of the 9–10 bond from
trans to cis. Desaturation by PDS is followed by the isomerization of the 15-cis bond of ζ-
carotene to trans, which can be mediated either by light or by the Z-ISO isomerase. Then,
ZDS carries out the stereospecific abstraction of protons from 7 and 7′ which results in the
formation of the 7 and 7′ cis bonds in 7,9,9′,7′-tetra-cis-lycopene. However, 7,9,9′,7′-tetra-
cis-lycopene is not a substrate for β or ε-cyclases. 118,187 Therefore, the formation of the
poly-cis intermediates requires the recruitment of an additional isomerase to generate the all-
trans-lycopene substrate for cyclization. 169 The last enzyme, CRTISO, fulfills a critical role
in converting the cis-double bonds introduced by PDS and ZDS to all-trans in plants and
cyanobacteria.
3.3.2 CIS-TRANS isomerases—The source of the 15-cis-double bond in phytoene as
found in most plants, cyanobacteria and alga can be traced to the PSY activity from such
organisms. 188 While PDS is active and in fact prefers 15-cis substrates, 169 ZDS is only
active against substrates with a 15-trans conformation. 169 In sun exposed tissues, the 15-cis
bond can be photoisomerized to trans to provide substrates for ZDS, 169 how-ever, in dark
tissues, such as etiolated plants, a light-independent mechanism is required. A mutant in the
Z-ISO gene of maize, referred to as pale yellow 9 (y9), was shown to accumulate 9,15,9′-tri-
cis-ζ-carotene in dark tissues indicating a possible impairment in the light-independent
mechanism of isomerization of the 15-cis bond. 171b,189 A mutant screen for impaired
carotenoid formation in dark germinated seeds led to the identification of the Z-ISO enzyme
which converted 9,15,9′-tri-cis-ζ-carotene to 9, 9′-tri-cis-ζ-carotene in functional
complementation assays in E. coli also expressing GGPPS, PSY and PDS. 171c
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Z-ISO is a chloroplast localized transmembrane protein related to the NnrU family of
enzymes found in denitrifying bacteria. 171c,190 Expression of Z-ISO transcript is highly
correlated with the expression of other carotenogenic enzymes. Z-ISO homologs can be
found in plants and cyanobacteria. 171c Based on the central location of the double bond it is
predicted that Z-ISO recognizes the carotenoid molecule differently than what is proposed
for CRTI, PDS, ZDS or CRTISO which act on one half of the molecule. In addition, the lack
of sequence homology of Z-ISO to any known carotenogenic enzyme suggests possibly a
different mechanism of reaction.
There has been considerable evidence that tetra-cis-lycopene intermediates are formed
during carotenogenesis in plants. In fact, fruits of a well known tomato strain called
tangerine have a bright orange color and had been shown to accumulate cis-carotenes by
Zechmeister and Pauling. 191 The tangerine phenotype is conferred by mutations in the
CRTISO gene. Like Z-ISO, the activity of CRTISO is partially redundant in plant tissues
that are exposed to high levels of sunlight presumably as a result of the photoisomerization
of the tetra-cis-lycopene to all-trans. 192 Therefore, CRTISO-deficient plants can still
synthesize carotenoids, albeit, at slower rate and only in specific tissues. The expression of
CRTISO is subject to regulation by a protein belonging to Set Domain Group 8 (SDG8) of
histone lysine methyl-transferases suggesting CRTISO plays a key regulatory role in the
pathway. 193
The CRTISO gene was identified independently in cyanobacteria, tomato and A. thaliana
using different approaches based on biochemical complementation assays or a combination
of screens for carotene-deficient strains and map-based cloning. 192,194 Analysis of the
sequence of CRTISO indicates significant sequence homology to CRTI-type bacterial
phytoene desaturases but less so to the plant desaturases, PDS and ZDS. 192 Like CRTI,
CRTISO has an extended FAD binding domain which is also shared by protoporphyrinogen
oxidoreductases and monoamine oxidases. 154 However, unlike CRTI, CRTISO carries out a
reaction which has no net redox change.
In vitro assays of purified CRTISO reconstituted with cofactors indicate that CRTISO is a
FADred-dependent protein which requires reducing cofactors and a redox system for
activity. 118,170 Similarly to CRTI and IDI-2, CRTISO is not active when reconstituted with
5-deaza-FAD 115b,118,152c indicating the involvement of the lone electron pair of N5 of FAD
in a two electron transfer process. 157 In contrast to IDI-2, CRTISO does not incorporate
deuterium in the isomerized product which argues against an acid-base mechanism of
reaction. 118,195 It was observed that CRTISO recognizes carotenoid precursors with
adjacent 7,9-di-cis bonds as found in 7,9,9′-tri-cis-neurosporene, 7,9,9′-tetra-cis-lycopene
and 7′,9′-di-cis-lycopene. Importantly, CRTISO isomerizes both 7 and 9-cis bonds of one
end of the molecule simultaneously. Accordingly neither mono-cis, tri-cis nor symmetric
7,7′-di-cis- and 9,9′-di-cis-lycopene isomers can be detected as products of
CRTISO. 118,196b Cumulatively these findings suggest that CRTISO catalyzes a two-step
reaction recognizing sequentially one end then the other of the carotenoid
molecule. 118,196a,b The process of isomerization depends on the participation of the lone
electron pair of N5 of FADred and there is no evidence of incorporation of deuterium from
D2O into product in the course of isomerization. 118
The extended FAD binding domain first described in CRTI 154 is also shared by CRTISO
and by the mammalian enzyme retinol saturase (RetSat), which catalyzes the double bond
saturation of the apo-carotenoid retinol (vitamin A) to produce (13R)-all-trans-13,14-
dihydroretinol 196b,c,d and requires FADred and NADPH for hydrolysis (unpublished
observations). The sequence similarity of a cis-trans isomerase (CRTISO), a desaturase
(CRTI) and a saturase (RetSat) which act on similar substrates is consistent with a
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mechanism of cis-trans isomerization of isoprenoids with conjugated double bonds that
involves saturation of the cis bond followed by rotation and desaturation of the double bond
in trans. 197 A prediction of the structure of CRTISO in comparison with CRTI based on
multiple threading alignments and iterative threading assembly refinement (I-TASSER) 144
is shown in Fig. 10.
4. CYCLIZATION OF LYCOPENE
Cyclization of lycopene represents a bifurcation in the carotenogenic pathway leading to
carotenoids with either β or ε-ionone rings as initially proposed by Porter and Lincoln 167b
Each ψ-acyclic end of lycopene can be cyclized to produce either β-, ε-, or γ-ionone rings.
The type of end groups and type of ring substitutions found in a carotenoid are the most
important determinant of the function and fate of the carotenoid compound; meanwhile, the
range and type of modifications that can be found in the polyene chain are more limited.
Carotenoids that contain at least one unsubstituted β-ionone end group can become a source
of vitamin A, retinol, which can be used to generate signaling molecules such as retinoic
acid or visual chromophore, 11-cis-retinal in vertebrates. 12a,17c,198 Cyclization of lycopene
is carried out by enzymes belonging to several distinct families. 124,199 For this reason,
increases in the activity of β-versus ε-lycopene cyclases can channel lycopene toward the
production of provitamin A carotenoids with increased nutritional value. 200 The mechanism
and types of ionone-ring cyclization reactions are indicated in Fig. 11.
CRTY represents a large family of related lycopene β-cyclases found in most proteobacteria
but not in cyanobacteria. A related family of lycopene cyclases (LCY) is found in most
plants and cyanobacteria. LCY-type enzymes can be further divided into three subtypes
based on the type of ionone ring produced. There are LCY-enzymes which generate β-
(LCYB) or ε-ionone (LCYE) rings, and bifunctional enzymes that generate carotenoids with
either β or ε-ionone rings (LCYB/E). 201
CRTY was identified though the sequencing of carotenogenic clusters from the
photosynthetic bacteria Rhodobacter sphaeroides 202 and the non-photosynthetic bacteria
Pantoea agglomerans (formerly Erwinia herbicola). 203 LCY-type activity from the
chromoplasts of daffodil and pepper plants has been investigated and shown to require FAD
and NADPH cofactors. 196a,204 A LCYB-type enzyme from Syn-echococcus sp. was
identified as the target of the herbicide 2-(4-methylphenoxy)triethylamine hydrochloride
(MPTA) known to inhibit the formation of cyclic carotenoids. 201a,205 Use of introgression
lines and map-based cloning led to the identification of a plant β-cyclase, or LCYB, gene
responsible for the phenotype of the Beta and old-gold mutants 201c and of the ε-cyclase, or
LCYE, gene responsible for the Delta mutation. 201b Variations in the expression levels of
LCYE are correlated with alterations of the carbon flux towards carotenoids containing
either β- or ε-ionone rings. 200 Thus LCYE is a major target in efforts to increase the
nutritional value of staple crops through provitamin A biofortification. 200
The LCYB-type β-cyclases, catalyze the cyclization of one end of lycopene to γ-carotene
and subsequently the other to produce β-carotene. The LCYE-type ε-cyclases catalyze the
cyclization of one ring of lycopene to produce δ-carotene. A subsequent cyclization of the ψ-
acyclic end of δ-carotene by β-cyclases generates α-carotene. The LCYE enzyme of lettuce
(Lactuca sativa) can cyclize both ψ-ends of lycopene to generate an ε,ε-carotene-precursor
of lactucaxanthin. 206 Several specific domains and residues have been identified which
determine whether LCYE introduces one or two ε-ionone rings. 206 A fascinating
bifunctional LCYB/E-type enzyme employed by the cyanobacterium Prochlorococcus
marinus cyclizes lycopene to either β- or ε-ionone end groups to generate β,β-, β,ε- or ε,ε-
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carotene. 201d The amino acid sequences of all LCY-type enzymes includes a conserved
motif FLEET motif which is important for activity. 207
CRTY and LCY enzymes also show sequence homology to enzymes involved in ring
substitutions such as neoxanthin synthases (NSY) and capsanthin-capsorubin synthases
(CCS). CCS enzymes convert 5,6-epoxycarotenoids, such as antheraxanthin and
violaxanthin, into the corresponding κ-cyclic carotenoids, capsanthin and capsorubin found
in pepper plants. 208 CCS also exhibit β-cyclase activity. 209 A gene highly similar to CCS
was discovered in potato and tomato plants 210 and the encoded enzyme converted the 5,6-
epoxycarotenoid violaxanthin into neoxanthin, hence referred to as NSY. 210 In fact the gene
coding for tomato NSY 210b is the same as the gene that codes for tomato LCYB. 201c,211
Though the overall homology between the monomeric lycopene cyclases CRTY and LCY-
type enzymes is relatively low (20–25% identical and 40–50 % conservative substitutions)
there are several well conserved domains shared by both types of lycopene cyclase
enzymes. 199a,201c,212 Amongst these conserved domains, the pentapeptidic sequence,
LIEDT, includes an essential Glu residue which is required for the activity of
CRTY. 117b,207b The LIEDT motif is similar to the essential FLEET motif of LCY
enzymes. 207b Studies of purified LCY- and CRTY-type enzymes reconstituted with
cofactors indicate these cyclase enzymes share the use of FADred as a cofactor. 117
LCY, CRTY and CCS have been shown to require FADred and NADPH for activity. 117,213
Cyclization of lycopene by flavobacterial CRTY in the presence of D2O leads to the
stereospecific incorporation of deuterium in the zeaxanthin product. 214 Lycopene
cyclization by LCYB or CCS is inhibited by ammonium analogs. 207b,208,214 It has been
proposed that the mechanism of cyclization for CRTY and LCY-type enzymes is initiated by
proton attack 213a,214 involving the formation of tertiary carbocation which is stabilized by
the enzyme. 117 This is then followed by proton abstraction from C-6 or C-4 to afford β- or
ε-ionone end group, respectively. 207b,213a,214 In contrast to IDI-2, CRTI or CRTISO, CRTY
reconstituted with 1-deaza-FAD or 5-deaza-FAD is, in fact, active. This observation does
not support a role for FAD as an acid-base catalyst or in the formation of a radical pair
though single-electron transfer. 117b In line with this observation, it was proposed that the
role of the FADred is most likely to stabilize the carbocation intermediate. 117b,207a The
essential glutamate residue of the LIEDT motif was proposed to act as an acid base
catalyst. 117b Based on the highly similar sequence and response to inhibitors it is likely that
CCS and NSY also employ a similar mechanism. 117a,208,210
Gram-positive bacteria, archaea and halophilic bacteria employ a heterodimeric β-cyclase
encoded by two different genes CrtYc and CrtYd. 215 Members of this family are generally
small proteins (approx. 12 kDa) and bear a signature hPhEEhhhhhh motif where “h” is a
hydrophobic residue. The CrtYc and CrtYd-like domains of the equivalent β-lycopene
cyclases of archaea are fused into a single polypeptide. 215c,d
Fungi encode an intriguing family of enzymes that combine phytoene synthesis activity with
lycopene β-cyclization. 216 Two discrete enzyme domains are responsible for the phytoene
synthase and lycopene cyclase activities. 124,217 Studies of the CarRA enzyme of
Phycomyces suggest that the bifunctional enzyme evolved from the fusion of a gene coding
for a PSY and one coding for a lycopene cyclase. 216c,217 It is not clear if the fused
polypeptide CarRA is the mature catalytically active form of the protein or whether the
translation product is a protein precursor that requires cleavage to produce individual PSY
and lycopene cyclase enzymes. A putative protease cleavage site that separates the two
domains has been identified but not demonstrated. 216c The cyclase domain of the
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bifunctional fungal enzyme bears homology to the CrtYc subunit of bacterial heterodimeric
cyclases.
The genome of the green sulfur phototrophic bacterium Chlorobium tepidum does not code
for any homologs of the CRTY, LCY or of bifunctional phytoene synthase/lycopene cyclase
enzymes found in fungi. 218 Instead C. tepidum utilizes a novel β-cyclase enzyme, CruA,
which converts lycopene to γ-carotene and very low amounts of β-carotene. 199b
Interestingly, C. tepidum is one of the few bacteria that employs a poly-cis pathway
dependent on PDS-, ZDS- and CRTISO-type enzymes to convert phytoene to lycopene. 199b
Green sulfur bacteria also code for a paralog of CruA referred to as CruB which catalyzes β-
cyclization of the ψ-acyclic end of γ-carotene and neurosporene (7′,8′-dihydrolycopene) but
not lycopene. 219 Thus, CruB requires that the opposite end of the molecule than the one
cyclized to be either cyclic or unsaturated. Presumably CruA and CruB act sequentially to
cyclize lycopene to γ-carotene and then β-carotene.
CruA and CruB are part of the FixC dehydrogenase/oxidoreductase superfamily, 220 which
includes mostly electron transfer flavoprotein (ETF) oxidoreductases. ETF oxidoreductases
are a large family of flavoproteins which carry out one or two electron transfer to oxidize or
reduce various substrates. 221 The mechanism of cyclization by CruA, CruB is not currently
established, therefore, we do not know if the FAD cofactor is involved in electron, proton or
hydride transfer or whether it serves to stabilize a presumed carbocation intermediate. It is
important to note the frequent use of flavoproteins that carry out isomerization reactions
with no net redox change to perform biochemical transformations in the carotenoid synthesis
pathway.
In addition to green-sulfur bacteria, a paralog of CruA, referred to as CruP is also present in
cyanobacteria and in plants. 199b C. tepidum CruA has been shown to convert lycopene to γ-
carotene in complementation studies 199b,222 and is required for lycopene cyclization in
vivo. 199b However, the lycopene cyclization activity and physiological role of the CruP
paralog from cyanobacteria and plants is not quite clear. Neither complementation studies
with CruP 222 nor the carotenoid profile of CruP-deficient Synechococcus sp. PCC 7002 199b
support a role for CruP in cyclization of lycopene 222 despite earlier evidence of biochemical
activity. 199b There is, however, evidence that plant CruP plays a role in the reduction of
oxidative stress associated with cold or anoxic conditions. 222
5. RING SUBSTITUTIONS
Introduction of keto and hydroxyl groups are the most common ring substitutions seen in
carotenoids. The hydroxylation of β- or ε-ionone rings at the C-3 position leads to the
production of xanthophylls lutein and zeaxanthin. Xanthophylls play essential roles in
protection against photooxidative damage. 223 Two distinct classes of enzymes are involved
in the hydroxylation of carotenoids namely ferrodoxin-dependent non-heme diiron enzymes
and enzymes belonging to the cytochrome P450 family. Substitutions of the β-ionone ring of
provitamin A carotenoids, such as β-carotene, lead to formation of nonprovitamin A
xanthophylls. Accordingly, specific members of the β-ionone hydroxylase family have been
recognized as a critical target in breeding plants with a high provitamin A carotenoid
content. 224 The mechanism and types of ionone-ring substitutions reactions are indicated in
Fig. 11.
5.1 Carotene hydroxylation by nonheme diiron hydroxylases
The first carotene hydroxylases identified were those encoded by the carotenogenic clusters
of the Erwinia urdovora/herbicola (Pantoea) species 225 and later those of plants. 226 The
bacterial and plant enzymes share sequence homology (40% identity and 60% conserved
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substitutions) to each other. Their sequence also indicates similarity to nonheme diiron
oxidases (HYD) which are involved in the hydroxylation or desaturation of fatty acids,
sterols and other substrates. 226a,227 Specifically carotenoid β-hydroxylases from the HYD
family contain conserved histidine cluster motifs HX (2–3)(XH)H, which is thought to
coordinate a diferric oxo-bridged cluster. 228 The mechanism of reaction of HYD enzymes
was first examined in the case of methane monooxygenase 229 and shown to proceed
through a radical rebound (hydrogen atom abstraction–oxygen rebound) mechanism
reminiscent of the one also employed by cytochrome P450 enzymes.
Based on studies of the alkane monooxygenase AlkB 230 and the L-p-aminophenylalanine
hydroxylase, 231 a possible mechanism of carotenoid hydroxylation by HYD enzymes would
proceed through binding of dioxygen to the iron cluster to form a peroxodiferric
intermediate. This is followed by hydrogen abstraction from C-3 and formation of an alkyl
radical which rebounds to form the hydroxylated ionone ring. Both plant and bacterial HYD
enzymes hydroxylate β-ionone rings at the C-3 position and are not efficient at
hydroxylating ε-ionone rings. 226a Analysis of purified and reconstituted HYD enzymes
showed that HYD hydroxylases are ferredoxin-dependent. 226b A related family of HYD
enzymes coded by Adonis aestivalis carry out the desaturation of the 3–4 bond or the
introduction of hydroxyl group at the C-4 position in β-ionone. 232 The fact that HYD
enzymes can also carry out the desaturation of the β-ionone ring offers support for the
mechanism proposed for the HYD β-cyclases.
Cyanobacteria also code for enzymes, represented by CrtR, which are involved in the
hydroxylation of C-3 of β-ionone rings. The sequence of CrtR indicates the presence of the
histidine-rich motifs found in the HYD family. 228b,233 However, the overall sequence of the
CrtR is homologous to β-carotene ketolases of the CrtW-type rather than to the β-
hydroxylases HYD enzymes from other bacteria and plants. 228b,233a
Members of, yet, another family of carotenoid hydroxylases found in marine proteobacteria
were shown to catalyze the hydroxylation of the β-ionone at the C-2 position. 234 The
sequence of these enzymes also indicates the presence of the histidine rich motifs associated
with enzymes belonging to HYD family but the overall homology to other HYD-type β-
hydroxylases is low. The C-2 hydroxylase recognizes β-ionone groups with a 4-keto or a 3-
hydroxy substitution.
These examples illustrate that HYD family enzymes with apparently different evolutionary
origin have been adapted to carry out carotene hydroxylation in various organisms. Perhaps
use of HYD enzymes in ionone ring hydroxylation is a reflection of convergent evolution.
Other HYD enzymes that have been recruited in carotenoid synthetic pathways include the
plastid terminal oxidase which oxidizes plastoquinol to plastoquinone thus transferring the
electrons generated by phytoene desaturases to oxygen, the terminal acceptor. 178,235
5.2 Carotene hydroxylation by cytochrome P450 enzymes
The dihydroxy α-xanthophyll lutein is the most abundant xanthophyll found in plants, 236
yet, for a long time the identity of enzymes responsible for the hydroxylation of ε-ionone
rings remained elusive. Genetic evidence suggested that the enzyme responsible for
hydroxylation of ε-ionone rings in A. thaliana was associated with the lut1 locus. 237 This
observations led to the identification of the gene coding for the ε-hydroxylase through map-
based cloning. 238 In contrast to the previously known carotenoid hydroxylases, the novel ε-
hydroxylase was identified as a cytochrome P450 enzyme member of the CYP97C
family. 238 CYP97C preferentially hydroxylates ε-ionone rings but it can also carry out β-
ring hydroxylation in vivo. 239 A second P450 enzyme from the CYP97A family was found
to hydroxylate β-ionone rings. 240
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It is not clear what dictates the substrate specificity of the CYP97C family for ε-ionone rings
while the related CYP97A prefers β-ionone rings. It has been suggested that CYP97C works
in conjunction with CYP97A β-hydroxylases form lutein by preferentially hydroxylating the
ε-ionone rings of substrates whose β-ring is already hydroxylated. 240–241 There is also
evidence that the various carotenoid hydroxylases work cooperatively in the production of
xanthophylls. 242 Ablation of the four carotene hydroxylases of A. thaliana namely the two
HYD and the two P450 family members results in a complete lack of xanthophylls. Thus,
the four genes represent the full complement of carotenoid hydroxylases in this plant. 236
Nevertheless, there is evidence that a related plant P450 enzyme belonging to the CYP97B
family can catalyze the hydroxylation of the β-ionone ring of α-carotene when
overexpressed in transgenic plants but the physiological role of the CYP97B-mediated
hydroxylation is still unclear. 243
Interestingly, other P450 superfamily members found in vertebrates and cyanobacteria carry
out the hydroxylation of the β-ionone ring of the C20 apocarotenoid retinoic acid. 244 The
sequence homology and similar mechanism of enzymes involved in the similar
biotransformation of carotenoids and apocarotenoids reflects an important functional and
evolutionary relationship. 197b
5.3 Carotene ketolases
The C-4 keto substitution is a very common modification of carotenoids synthesized by
cyanobacteria. The ketocarotenoids include many species which have high commercial
value and potential clinical use. Carotenoid ketolases that belong to two distinct families
have been described. One family of carotene ketolases represented by the Synechocystis
CrtO acts asymmetrically to introduce a 4-keto group in the β-ionone ring of one end of β-
carotene to produce at first echinenone and subsequently ketolates the other end to produce
canthaxanthin. 245 The enzymes involved in the introduction of keto-groups are indicated in
Fig. 12.
CrtO shows similarity to CRTI and is proposed to employ a similar mechanism based on the
formation of a carbocation intermediate which reacts with OH- to form a 4-hydroxy and
subsequently a 4-dihydroxy derivative. 246 Though, the 4-dihydroxy derivative was not
detected in the course of the reactions catalyzed by purified CrtO, 246 it was shown to be
substrate for CrtO leading to the formation of 4-keto group by elimination of water. 246
The second group of carotenoid ketolases are represented CrtW-type enzymes found in
marine bacteria and green alga. Analysis of extracts of E. coli which overexpress CrtW
indicates CrtW catalyze the introduction of keto groups at C-4 to produce canthaxanthin. 247
Complementation assays in E. coli that express carotenogenic genes indicate that, in contrast
to CrtO, CrtW can also introduce 4-keto groups into the substituted β-rings of zexanthin
leading to the formation of ketocarotenoids such as astaxanthin. 233b,248 Also differently
than CrtO, the CrtW-catalyzed reaction requires oxygen but not dinucleotide cofactors based
on the enzyme activities of lysates of E. coli expressing CrtW. 247d The sequence of CrtW
enzymes shows homology to the HYD-type β-hydroxylase CrtR from cyanobacteria. 233a
Similar to the CrtR several histidine-rich motifs commonly found in HYD family of
oxidases are required for the activity of CrtW 249 possibly suggesting CrtW employs a
similar mechanism to one proposed for HYD-type β-hydroxylase enzymes. 247d,249
5.4 Epoxidases and de-epoxidases
Zeaxanthin can be further modified by the epoxidation of its β-ionone rings at the 5–6
position to successively produce antheraxanthin and later violaxanthin in reactions catalyzed
by zeaxanthin epoxi-dase (ZEP). 250 The reverse reactions are catalyzed by the enzyme
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violaxanthin de-epoxidase (VDE). 251 The interconversion of zeaxanthin and violaxanthin
by ZEP and VDE creates a xanthophyll cycle which plays a central role in the regulation of
photosynthetic energy conversion. 3a,252 Plants with mutations in the ZEP and VDE genes
are characterized by alterations in NPQ of chlorophyll fluorescence. 3
Based on the analysis of crude preparations of thylakoid membranes, ZEP is a flavin-
dependent monooxygenase which requires NADPH and oxygen. 253 Like other flavin-
dependent monooxygenases, it is proposed that ZEP carries out electron transfer from
reduced flavin to oxygen to form a hydroper-oxyflavin species which then carries out
electrophilic attack on the ionone ring to incorporate epoxide. 254 There is little data
regarding the residues involved in the epoxidation reaction due to difficulties in both
heterologous expression and purification of ZEP. 250
Based on the analysis of the sequence of ZEP and VDE it was predicted that that both
enzymes contain a lipocalin fold found in proteins that bind hydrophobic ligands. 255
Analysis of the crystal structure of the central domain of VDE confirmed this prediction as
the central domain of VDE assumes the characteristic eight stranded antiparallel β-barrel
found in lipocalins. 256 The lipocalin domain of VDE was crystallized at both pH 5 and
7, 256 respectively. The two structures show that the lipocalin fold undergoes a pH-
dependent transition from closed (neutral conditions) to open (acidic conditions). 256 This
transition provides a mechanistic explanation for the effects of pH on the activity of VDE
which is active and associated with the thylakoid membrane at low pH and inactive and not
membrane bound at neutral pH. 257 Several key residues involved in the pH-dependent
transition have been identified. 257b In addition to the lipocalin fold, the sequence of VDE
indicates the presence of a conserved cysteine-rich N-terminal domain whose role is not
understood and a glutamate-rich C-terminal domain which is important for the association
with the thylakoid membrane. 258 The enzymatic mechanism involved in the de-epoxidation
reaction carried out by VDE is not entirely clear.
5.5 Other modifications
In addition to the classic carotenoid ring substitutions described above, there are many more
possible substitutions found in less common carotenoids. Purple sulfur bacteria code for a β-
ionone desaturase/methyltransferase, CrtU, which converts β-carotene to isorenieratene, a
carotenoid with aryl end groups. 259 CrtU is a flavoprotein which bears some similarity to
CRTI. 259
The acyclic ψ-end groups of neurosporene and lycopene can also be further modified to
produce acyclic carotenoids such as spheroidene and spirilloxanthin, respectively, by the
purple photosynthetic bacteria. 260 These transformations require a 1,2-hydratase, a 3,4
desaturase and a methyltransferase, respectively, represented by the CRTI/CrtC, CrtD and
CrtF enzymes. 261
There are over 700 carotenoid species in nature representing one of the most diverse classes
of biological compounds and many continue to be discovered. This diversity is a result of
the large number of possible substitutions and the combinatorial use of a finite enzymatic
repertoire by living systems to produce alternate outcomes. As we will continue to discover
more enzymes responsible for carotenoid modifications and we will begin to explore their
structure and mechanisms, we will have an unprecedented molecular understanding of these
pathways and we will be in a position to predict the enzymes necessary to synthesize any
carotenoid species desired.
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One of the most important questions that has puzzled the carotenoid field for decades is in
regards to the origin and advantage of the poly-cis pathway for lycopene synthesis in plants
and cyanobacteria. 160 Why would cyanobacteria and plants use four separate enzymes and a
convoluted mechanism to form lycopene when bacteria can accomplish the same goal with
one single enzyme, CRTI. An explanation proposed is that the early intermediates of
carotenoid synthesis are more energetically stable as cis rather than as trans-isomers. 262
Alternatively, it was proposed that one of the advantages of the poly-cis pathway is that the
use of redox cofactors by the desaturases (PDS and ZDS) and isomerases (CRTISO) of the
poly-cis pathway ties lycopene formation to the availability of redox cofactors, hence, the
metabolic state of the photosynthetic cell. 160 This is a persuasive argument which is
reminiscent of other regulatory models proposed for the regulation of secondary
metabolism. However, in light of the requirement of redox cofactors by CRTI, it is apparent
that a similar mechanism of redox regulation of carotenogenesis could operate even in the
case of the CRTI pathway. Therefore, it is still not clear why cyanobacteria would need to
develop a more complex pathway.
A recently developed concept that could explain the role of the poly-cis pathway in
carotenoid synthesis is that the intermediates of this pathway have additional physiological
roles that extend beyond serving as precursors of lycopene. 139 This concept is based on the
analysis of the phenotype of several mutant strains of tomato lacking carotenoid synthetic
genes. It has been known since 1950’s that the tangerine mutation of tomato plants is
epistatic to the yellow-flesh mutation in tomato plants. 263 The yellow-flesh mutation was
identified as a mutation in the PSY gene 264 and, more recently, the tangerine mutation was
identified as a mutation in CRTISO. 192a Bearing in mind the sequence of reactions in the
lycopene synthetic pathway in plants proceeds in the order PSY→PDS→Z-
ISO→ZDS→CRTISO, the epistatic effect of tangerine on yellow-flesh is very unusual. This
is because plants deficient in both PSY and the downstream gene CRTISO resemble the
phenotype of plants deficient in CRTISO when logic dictates it should be the other way
around. Though the exact nature of the recessive yellow-flesh mutation in PSY is not known,
it appears that it is not a result of deleterious mutation in the PSY coding region. Instead it is
proposed that the yellow-flesh mutation causes a decrease in PSY expression by altering a
cis-acting transcriptional element or epigenetic factor. Moreover, plants lacking both PSY
and Z-ISO resemble PSY in accordance with the sequence of synthetic reactions. The best
explanation, thus far, for the epistatic mechanism of tangerine on yellow-flesh is that lack of
CRTISO causes accumulation of intermediates of the poly-cis pathway which leads to the
upregulation of the expression of PSY. 139 The feedback regulation of early carotenoid
synthetic genes in response to a block in upstream metabolism represents a paradigm shift in
our understanding of the mechanism and regulation of carotenoid synthesis, and of
metabolic regulation in general. A similar phenomenon is encountered in the case of the
MEP pathway where DXS protein levels are upregulated in response to a block in the MEP
pathway or in response to an overexpression of carotenogenic genes such as PSY. 51b,53
The molecular details of a signaling pathway that regulates carotenogenesis in response to
the levels of carotenoid precursors are still unclear. It is not known if poly-cis pathway
intermediates signal through specific receptors or whether they are converted to other
bioactive metabolites. In addition to known intermediates of the poly-cis pathway, such as,
tetra-cis-lycopene and tri-cis-neurosporene, CRTISO-deficient, tangerine, tomato fruits also
accumulate apocarotenoids derived from their degradation. Some of the norisoprenoids
which accumulate in tangerine fruits include pseudoionone, dihydro-apo-farnesal 6-
methyl-5-hepten-2-one and significant levels of geranylacetone. 265. It is, therefore, possible
that such apocarotenoid metabolites act as a readout of the carbon flux through the
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carotenoid pathway allowing the organism to further tune carotenoid production. In support
of this hypothesis, genes of poly-cis pathway enzymes (PSY, ZDS and PDS) were also
shown to be induced in another mutant of CRTISO, namely the yellow–orange fruit flesh
(yofI) mutant which also accumulates significant levels of apocarotenoids. 266
On a fundamental level, the basic question that needs to be addressed first is with regards to
the mechanism of catalysis by the desaturase/isomerase enzymes PDS and ZDS. Could the
poly-cis pathway be a simple consequence of the choice by cyanobacteria and plants to use
of mixed function desaturase/isomerase enzymes such as PDS and ZDS for lycopene
synthesis – A mechanistic and structural understanding of the enzymes involved in the later
steps of carotenoid metabolism would answer many of these questions.
Despite much progress in the understanding of the structure and mechanism of enzymes
involved in the early steps of carotenoid synthesis involving isoprenoid and phytoene
precursor synthesis, we still have a limited understanding of the later steps of carotenoid
synthesis. Crystal or NMR structures have been reported for all of the enzymes involved in
IPP and DMAPP synthesis. This knowledge has provided a detailed molecular
understanding of the chemistry of isoprenoid precursor synthesis. Though the structure of
PSY, the first enzyme of the pathway committed to carotenoid production, has not been
reported, the mechanistic and structural studies of squalene synthase and CRTM have shed
light on its mechanism and structure.
With the exception of the recently reported structure of CRTI and of a domain of VDE, there
are no reports of structures for the enzymes involved in the synthesis of lycopene, lycopene
cyclization or ionone-ring substitutions. Much of the paucity of structures and the limited
enzymological understanding of enzymes involved in the later steps of carotenoid synthesis
can be attributed to the notorious difficulty in handling such enzymes. Many of the enzymes
involved in transformations of C40 isoprenoids are membrane-bound and use ligands that
are some of most light sensitive and hydrophobic compounds known in biology. In addition,
many carotenogenic enzymes require specific redox cofactors for activity. The fact that we
know or strongly suspect the role of a great majority of the carotenoid enzymes and that for
the most part we can predict the pathways that can generate a novel carotenoid is truly
remarkable. It is also a testament to the tenacity and superb skills of the many biochemists
and geneticists which have dedicated their studies to carotenoid biology over the past
century.
Metabolic engineering of carotenoid synthetic pathways using a combinatorial approach has
led to the efficient production of interesting carotenoids of high commercial value and
pharmaceutical potential. 267 The occurrence of many possible xanthophyll enantiomers
have made synthetic chemical approaches too laborious, costly or simply not feasible for
industrial scale production. In addition, many of the natural sources of highly sought after
carotenoids are difficult to obtain or to culture on an industrial scale. Heterologous
expression in bacteria, yeast or plants can overcome many of the problems associated with
cultivation or use of natural sources and allows for strict pathway control. 49,268
Combinatorial use of enzymes involved in the carotenogenic pathway has also led to the
production of unique carotenoids that have, so far, not been documented in nature. Such
examples include the novel violet phillipsiaxanthin and carotenoids with C45 and C50
backbones. 269 Many of these unusual carotenoids have very interesting physical and
chemical properties which could be exploited for research, food colorant or clinical use.
Provitamin A carotenoids such as β-carotene and β-cryptoxanthin are the most important
sources of vitamin A in the world population. 270 Dietary provitamin A carotenoids are
oxidatively cleaved by carotenoid monooxygenase CMO1 to retinaldehyde. 271
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Retinaldehyde is reduced to vitamin A, retinol which can be further esterified for storage as
retinyl esters or can be converted to several active retinoids, such as 11-cis-retinal, the visual
chromophore, 11e,f,12a,272 or all-trans-retinoic acid (ATRA), a ligand of nuclear hormone
receptors which carries out essential roles in a multitude of biological processes throughout
life. 11b17a,b Despite the well recognized role of vitamin A in carrying out essential functions
in embryonic development, vision, immunity and tissue differentiation, vitamin A deficiency
is still one of the most important human health problems. Though, vitamin A
supplementation prevents 350,000 childhood deaths annually in developing countries, yet,
another 500,000 children still die and 250,000 become blind as a result of its deficiency 273
One very important advance in combating vitamin A deficiency in developing countries
relies on the redirecting carotenoid synthesis towards the synthesis of provitamin A
carotenoids in staple food crops. Biofortification efforts through genetic engineering of
major food crops such as rice, tomato, maize potato and cassava have identified key rate-
limiting steps, genes and regulatory factors that can lead to increase production of
provitamin A carotenoids. 21d,119b,200,224,274 Today, the content of β-carotene in Golden
Rice approaches 37 μg/ g milled uncooked rice. Supplementation of school children diet
with Golden Rice supplies vitamin A as effectively as a supplementation of an emulsion of
pure β-carotene in oil and is even better than spinach. 274i,275 Much of this progress would
not have been possible without an intimate knowledge of the carotenoid synthetic pathways
tediously worked out by carotenoid biologists for the past century.
Our current knowledge of the carotenoid synthetic pathways is still limited in two important
aspects which are essential considerations in devising approaches to meet plant
biofortification goals. The steady state levels of carotenoids that accumulate in a cell are
determined not just by synthetic but also by factors and pathway that control the degradation
of carotenoids. Carotenoids can be oxidatively cleaved by both enzymatic and non-
enzymatic means 18a,276 to produce many apocarotenoid metabolites. Some of these
apocarotenoids include strigolactones and abscisic acid that play vital roles in plant
metabolism. 15b,277 Others apocarotenoids include volatile norisoprenoid compounds such
as β-ionone, geranial and citral that impart a pleasant aroma to fruits and vegetables. 265a,278
Elucidation of the enzymatic and non-enzymatic processes that govern carotenoid cleavage
could help achieve higher levels of carotenoids in staple crops. Alternatively, creating
metabolic storage sinks to sequester carotenoids and protect them from degradation can also
lead to significantly higher content of carotenoids in food crops. 279
Though we know the role of many of the individual enzymes involved in carotenoid
synthesis, we do not know what the complete pathway looks like in terms of its three
dimensional multi-enzyme organization. There is extensive evidence that many of the plant
carotenogenic enzymes interact with one another forming complexes associated with the
plastid membrane. 92,235 Association of enzymes that carry out consecutive steps in the
pathway can allow for substrate channeling and avoid loss of intermediates to side reactions.
It is also clear that many of the carotenogenic enzymes require redox factors for activity
which need to couple to a redox chain and final electron acceptors. Therefore, besides
focusing on individual enzymes, future carotenoid research will need to further investigate
the macro-molecular structure and assembly of the multiprotein carotenogenic complex.
Future avenues of research need to involve post-reductionist approaches using systems
biology, structural biology, cryoelectron tomography and high-resolution optical
imaging. 280 Such knowledge will provide a better understanding of the cellular
environment of carotene synthesis and its complex interactions with other pathways within
the cell.
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CMK 4-(cytidine 5′-diphospho)-2C-methyl-D-erythritol kinase
CMP cytidine 5′-monophosphate
CRTI bacterial-type phytoene desaturase
CRTISO carotene isomerase
CrtM dehydrosqualene synthase
CrtO β-carotene ketolase, only unsubstituted β-rings
CrtW β-carotene ketolase, including carotenoids with substituted β-rings






FAD flavin adenine dinucleotide
FADred reduced FAD (FADH• or FADH2)
FMN flavin mononucleotide
FPP farnesyl diphosphate
FPPS farnesyl diphosphate synthase
G3P glyceraldehyde 3-phosphate
GGPP geranylgeranyl diphosphate
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HYD nonheme diiron oxidase
IDI-1 IPP-DMAPP isomerase type 1
IDI-2 IPP-DMAPP isomerase type 2
IPP isopentenyl diphosphate
KET β-carotene ketolase









MVD mevalonate diphosphate decarboxylase
NADP+ nicotinamide adenine dinucleotide phosphate, oxidized form
NADPH nicotinamide adenine dinucleotide phosphate, reduced form
NPQ non-photochemical quenching
NSY neoxanthin synthase
P450 heme-binding cytochrome P450
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Fate of the radiolabel from [1-13C]–glucose (red circle) in the formation of IPP via either
the MEP pathway (left pathway) or via MVA pathway (right pathway). Adapted and
reprinted with permission from Reference 35. Copyright 2004 American Chemical Society.
Moise et al. Page 44














Synthesis of the C5 isoprenoid precursors IPP and DMAPP. The plastidial MEP pathway
from plants and eubacteria (shown in top diagram) leads to the production of both IPP and
DMAPP (indicated in inset dashed-line box). A possible source of CDP-ME from the
pentose phosphate pathway is also suggested. The MVA pathway from metazoa and fungi
and a variation of the pathway found in archaea leading to the formation of IPP are
illustrated in bottom diagram adapted from 281. HMG-CoA can also be obtained from
branched-chain amino acid leucine via 3-methylglutaconyl CoA. IPP and DMAPP can be
interconverted by IDI-1 or IDI-2. Adapted and reprinted with permission from Reference
281. Copyright 2008 Springer.
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The mechanism of reaction, structure and key features of DXS in comparison with
transketolase. At left, the structure of the DXS dimer in complex with TPP (red) based on its
reported structure (PDB 2O1S) with the subunits colored either blue or yellow. 46 Inset
shows the orientation of TPP and the critical E370 and R398 residues of DXS colored by
heteroatoms. Right structure shows a monomer of the related transketolase structure (PDB
3MOS) (green) in combination with TPP (red). 282 Inset shows the important transketolase
E157 and Q189 residues involved in binding TPP colored by heteroatoms. The mechanisim
of reaction of DXS is adapted and reprinted with permission from Reference 44. Copyright
2003 American Chemical Society.
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The mechanism of reaction, structure and key features of DXR and MCT. The top structure
shows the DXR dimer with the subunits colored either blue or yellow in association with the
inhibitor fosmidomycin (FOM in red) based on its reported structure (PDB 1ONP). 61c Inset
indicates FOM and the critical residues D150, E152 and E231 (colored by heteroatoms) that
coordinate the divalent ion (Mn2+) within the active site of DXR. The MCT dimer structure
with the subunits colored either blue or yellow in complex with its product CDP-ME (red) is
based on its reported structure (PDB 3Q80). Inset shows the orientation of CDP-ME in
relation to the Mg2+ ion within the active site of MCT. The mechanism of reaction of DXR
is adapted from with permission from Reference 58. Copyright 2008 American Chemical
Society.
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The mechanism of reaction, structure and key features of CMK and MDS. The structure of
the CMK dimer with the subunits colored either blue or yellow in association with a
nonhydrolyzable ATP analogue (AMP-PNP) and substrate (CDP-ME) (both in red) based
on its reported structure (PDB 1OJ4) 73a Inset shows the orientation of AMP-PNP and CDP-
ME forming hydrogen bonds with residues K10 and D141 (colored by heteroatoms) the
active site of CMK. The MDS trimer structure with subunits colored blue, yellow or red in
complex with cytidine 5′-diphosphate (CDP) (red) based on its reported structure (PDB
1GX1). 76a Inset indicates the orientation of CDP in relation to the Mn2+ and Zn2+ ions and
the MDS active site residues E135, H10 and H42 (colored by heteroatoms). Please note the
active site of MDS is formed by residues derived from adjacent subunits.
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The mechanism of reaction, structure and key features of HDS, HDR, IDI-1 and IDI-2. The
reductive reactions carried out by HDS and HDR indicate the coupling to electrons obtained
via flavodoxin and flavodoxin reductase (FldA) from NADPH. Top left, the HDS dimer
structure with the subunits colored either blue or yellow based on its reported structure (PDB
3NOY). 87a Inset indicates the critical C265, C268, C300, and E307 residues of HDS that
coordinate the iron sulfur cluster ([4Fe-4S]) (colored by heteroatoms). Top right, the HDR
dimer structure with the subunits colored either blue or yellow based on its reported structure
(PDB 3KE8) in complex with HMBPP substrate (red). 88c Inset indicates the iron sulfur
cluster ([4Fe-4S]) and the critical Q166, T167, T168 and E126 residues (colored by
heteroatoms) of HDR. Middle right, the structure of E. coli IDI-1 monomer (PDB 1NFZ)
following treatment with the irreversible inhibitor 3,4-epoxy-3-methyl-1-butyl
diphosphate. 109a Inset indicates the orientation of 4-hydroxy-3-methyl butyl diphosphate
linked to the sulfur group of C67 and in relation to the Mg2+ and Mn2+ divalent ions and the
critical residues E116, Y104 (colored by heteroatoms) of IDI-1. Bottom right, the structure
of IDI-2 tetramer with each subunit colored in either blue, orange, teal or yellow based on
its reported structure (PDB 3B05). 116a Inset indicates the critical residue Q160 and the
reduced FMN (FMNred) cofactor of IDI-2. Bottom left, diagram indicates the mechanism of
the HDS, HDR and IDI-1 and IDI-2 catalyzed reactions adapted from reference with
permission from reference 283. Copyright 2007 American Society for Biochemistry and
Molecular Biology.
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The poly-cis phytoene synthesis pathway from plants, cyanobacteria and the CRTI-based
phytoene synthesis pathway from other carotenogenic bacteria. Newly desaturated or
isomerized bonds are colored red.
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The mechanism of cyclic condensations, structure and key features of GGPPS. Top,
mechanism of the 1′-4 head-to-tail condensation condensation reaction catalyzed by
GGPPS. The allylic substrate (DMAPP shown) binds the allylic binding site in blue while
IPP binds to the homoallylic binding site indicated in yellow. The condensation cycle
proceeds through ionization, condensation and release steps. Bottom, the structure of
GGPPS dimer (green and yellow subunits) in association with isoprenoid substrates (red)
based on its published structure (PDB 2E8U). 130b Inset shows the orientation of IPP bound
to either the natural, homoallylic binding site or the non natural allylic binding site of
GGPPS. Binding to the allylic site is mediated by the Mg2+ cluster which is coordinated by
the residues D80, D84 of the DDxxD motif. Active site residues R90, D214 and H73 that are
proposed to participate in substrate binding are also shown (residues and substrate IPP are
colored by heteroatoms). The mechanism of reaction of GGPPS is adapted and reprinted
with permission from Reference 284. Copyright 2008 American Chemical Society.
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The enzymatic reaction, structure and key features of CrtM and a model of PSY. Top,
diagrams illustrate the CrtM and PSY-catalyzed reactions. Bottom left, the structure of CrtM
bound to farnesyl thiodiphosphate in either the allylic or homoallylic site based on published
structure (PDB 2ZCP). 146 The divalent metal ion cluster is also indicated. Bottom right, a
prediction of the structure of A. thaliana PSY based on multiple threading alignments and
iterative threading assembly refinement (I-TASSER) 144 is also shown for comparison. The
mechanism of reaction of CrtM is adapted and reprinted with permission from Reference
285. Copyright 2009 American Chemical Society.
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The enzymatic reaction, structure and key features of CRTI and CRTISO. The desaturation
reaction catalyzed by CRTI is shown in comparison with the saturation-isomerization-
desaturation reaction catalyzed by CRTISO. Bottom left, the structure of CRTI is based on
its reported structure (PDB 4DGK) indicating the FAD binding β-α-β fold (pink). 152c
Bottom right, a prediction of the structure of tomato CRTISO using I-TASSER 144 is
colored in teal and is superimposed on the CRTI structure colored in gold. The FAD binding
domain of CRTISO (purple) and that of CRTI (pink) are indicated. Below, the alignment of
the sequence of hexahistidine tagged-CRTI (as used to generate the PDB 4DGK structure)
and tomato CRTISO with identical residues in white letters on black background and
conserved substitutions in black on grey background. The extended FAD binding domain
shared by CRTI, CRTISO and protoporphyrinogen oxidoreductases and monoamine oxidase
is highlighted in yellow. The diagrams depicting reactions of CRTI and CRTISO is adapted
and reprinted with permission from reference from reference 197b. Copyright 2005 Elsevier.
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The mechanism of main types of ionone-ring cyclization and substitution reactions.
Cyclization and formation of β- or ε-ionone rings, hydroxylation and epoxidation reactions
are boxed in purple, orange and blue respectively. The reactions occurring in pepper plants
leading to the conversion of epoxidized ionone rings to κ-rings are shown in red box. Newly
acquired substitutions or modifications are colored red. The scheme of ionone-ring
cyclization and substitution reactions is adapted from and reprinted with permission from
reference 18a. Reproduced by permission of The Royal Society of Chemistry
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The main enzymes involved in the introduction of keto-groups in carotenoids in
cyanobacteria. Newly acquired keto-groups are colored red.
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